Anubis Bio

Anubis Bio

Signal active

Organization

Contact Information

Overview

Anubis Bio has USPTO patented Microbiome-Cleanser (TM) natural food platform that quickly resolves GI-distress-diarrhea in animals starting with dogs (www.doggystat.com). Two major B2B distribution partnerships signed in 2021.

About

Industries

Biotechnology, Pet, Health Care, Wellness, Dietary Supplements, Nutrition, Veterinary

Founded

2018

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Anubis Bio headquartered in United States, North America, operates in the Biotechnology, Pet, Health Care, Wellness, Dietary Supplements, Nutrition, Veterinary sector. The company focuses on Biotechnology and has secured $116.5M in funding across 112 round(s). With a team of 1-10 employees, Anubis Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Anubis Bio, raised $40.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

4

Investors

1

Lead Investors

0

Total Funding Amount

$1.0M

Details

4

Anubis Bio has raised a total of $1.0M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Seed
2020Seed1.0M
2018Seed
2019Early Stage Venture40.0K

Investors

Anubis Bio is funded by 10 investors.

Investor NameLead InvestorFunding RoundPartners
Anubis Bio-FUNDING ROUND - Anubis Bioundefined
New York Angels-FUNDING ROUND - New York Angelsundefined
Anubis Bio-FUNDING ROUND - Anubis Bio40.0K
Lubbock Angel Network-FUNDING ROUND - Lubbock Angel Network40.0K

Recent Activity

There is no recent news or activity for this profile.